TRILUMINATE: Quality of life after transcatheter tricuspid-valve repair vs. medical therapy in severe TR

Reported from TCT 2023

Luigi Biasco interviews Suzanne V. Arnold about the results of the randomized TRILUMINATE pivotal trial which she presented during the TCT Congress 2023 in San Francisco

The findings support the use of T-TEER with the TriClip device for improvement in the symptoms, functional limitations, and quality of life in patients with severe tricuspid regurgitation.

Latest news from TCT 2023

Authors

Luigi Biasco

Interventional cardiologist / Cardiologist

OSPEDALE CIRIÈ - Ciriè, Italy

Suzanne V. Arnold

Interventional cardiologist / Cardiologist

University of Missouri - Kansas city, United States of America

Join the discussion

No comments yet!